No Data
Medical Developments International Reports Strong Q3 FY25 Performance
Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Medical Developments International Limited (ASX:MVP) Shares Could Be 38% Below Their Intrinsic Value Estimate
Medical Developments International Target Price Cut 56% to A$0.71/Share by Bell Potter>MVP.AU
Shareholders in Medical Developments International (ASX:MVP) Have Lost 90%, as Stock Drops 13% This Past Week